Allarity Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Allarity Therapeutics, Inc. (ALLR) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.43 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-14
- Allarity Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.43M shares, a 72.90% increase year-over-year.
- Allarity Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 803.27K shares, a 212.95% increase year-over-year.
- Allarity Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 828.27K shares, a 6.41% increase year-over-year.
- Allarity Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-06-30 was 256.68K shares.
- Allarity Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 678.72K shares, a 271.71% increase from fiscal 2024.
- Allarity Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 182.59K shares, a 889.51% increase from fiscal 2023.
- Allarity Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 18.45K shares, a 99.90% decline from fiscal 2022.
- Allarity Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 19.17M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.43M shares 10-Q · filed 2026-08-14 | ||||||
| 2026-03-31 | 1.43M shares 10-Q · filed 2026-05-15 | ||||||
| 2025-12-31 | 678.72K shares 10-K · filed 2026-03-30 | ||||||
| 2025-09-30 | 678.72K shares 10-Q · filed 2025-11-14 | ||||||
| 2025-06-30 | 803.27K shares 10-Q · filed 2025-08-15 | 803.27K shares 10-Q · filed 2026-08-14 | |||||
| 2025-03-31 | 828.27K shares 10-Q · filed 2026-05-15 | ||||||
| 2024-12-31 | 182.59K shares 10-K · filed 2026-03-30 | ||||||
| 2024-09-30 | 182.60K shares 10-Q · filed 2025-11-14 | ||||||
| 2024-06-30 | 256.68K shares 10-Q · filed 2024-08-05 | 8.56K shares 10-Q · filed 2025-08-15 | |||||
| 2024-03-31 | 778.38K shares 10-Q · filed 2025-05-09 | 1.63M shares 10-Q · filed 2024-05-14 | |||||
| 2023-12-31 | 18.45K shares 10-K · filed 2025-03-31 | 11.07M shares 10-K · filed 2024-03-08 | |||||
| 2023-09-30 | 29.93K shares 10-Q · filed 2024-11-14 | ||||||
| 2023-06-30 | 69.09K shares 10-Q · filed 2024-08-05 | ||||||
| 2023-03-31 | 2.32K shares 10-Q · filed 2024-05-14 | ||||||
| 2022-12-31 | 19.17M shares 10-K · filed 2024-03-08 | ||||||
| 2021-09-30 | 190.97K shares 10-Q/A · filed 2022-05-17 | 9.55M shares 10-Q · filed 2021-11-23 | 215.12K shares 10-Q/A · filed 2022-05-17 | 10.76M shares 10-Q · filed 2021-11-23 | |||
| 2020-09-30 | 174.34K shares 10-Q/A · filed 2022-05-17 | 8.72M shares 10-Q · filed 2021-11-23 | 174.34K shares 10-Q/A · filed 2022-05-17 | 8.72M shares 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |